account_id none on file
legal_name Alto Neuroscience, Inc.
ticker ANRO
cik 1999480
domain altoneuroscience.com
linkedin_company_url https://www.linkedin.com/company/altoneuroscience/
entry_point_account_id none on file
name Alto Neuroscience Inc.
exchange NYSE
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 3 executives 1 family 0
why_nownone on file
callsnone on file
filings
General and administrative expenses also include professional fees for legal, patent, accounting, information technology, auditing, tax and consultin g services, travel expenses, and facility-related expenses, which include direct depreciation costs and allocated expenses for rent and maintenance of facilities and other operating costs.
filing / Aug 12, 2026 / receipt
General and administrative expenses also include professional fees for legal, patent, accounting, information technology, auditing, tax and consultin g services, travel expenses, and facility-related expenses, which include direct depreciation costs and allocated expenses for rent and maintenance of facilities and other operating costs.
filing / May 13, 2026 / receipt
On March 11, 2026 , Nicholas Smith , our Chief Financial Officer and Chief Business Officer , terminated a Rule 10b5-1 trading plan effective March 13, 2026.
filing / May 13, 2026 / receipt
executives
| Michael Hanley | Chief Operating Officer | - | receipt |
familynone on file
upcoming
| 2026-11-11 | earnings call | scheduled | ir |
changes
| 2024-05-21 | Chief Operating Officer, appointed | sec_8k |
mcp_package_hint
slug alto-neuroscience-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$